Major milestones and contributions in Chile and Latin America.
1938
Laboratorios SAVAL is born in Chile through the first line of ophthalmic products (Nicolich) manufactured in our country.
1950
First antibiotics launched in Chile: Sulfas.
1967
The company opens a new plant, moving its operations to Panamericana Norte, Santiago de Chile.
1968
Beta-lactams line is launched in Chile.
1970
SAVAL’s own line of antibiotics is launched.
1982
The first antiviral drug is launched in Chile: Acyclovir.
1983
The first anti-retroviral drug is launched in Chile: Zidovudine.
1987
The corporate building of Laboratorios SAVAL is opened.
1988
The Penicillin Plant is opened; SAVAL is the first pharmaceutical company in Chile complying with technical standards for the production of these medicines.
1989
Business operations are started in Bolivia through a local distributor.
1992
Business operations are started in Paraguay through a local distributor.
1992
Business operations are started in Peru through a local distributor.
1992
Business operations are started in Uruguay through a local distributor.
1994
Business operations are started in Panama through a local distributor.
1995
Business operations are started in Paraguay with an own subsidiary.
1995
Business operations are started in Ecuador through a local distributor.
1996
Farmaval Bolivia is established with an own subsidiary.
1998
Business operations are started in El Salvador through a local distributor.
1998
Farmaval Perú is established with an own subsidiary.
2001
First pharmaceutical company in Chile to obtain GMP certification.
2004 - 2005
SAP project is implemented.
2005 - 2006
A Distribution Center in the adjacent area to Laboratorios SAVAL premises in Chile is opened.
2007
Business operations are started in Haiti through a local distributor.
2009
Business operations are started in Dominican Republic through a local distributor.
2009
Business operations are started in Cuba through a local distributor.
2010
Business operations are started in Costa Rica through a local distributor.
2011
The first multipurpose plant of Laboratorios SAVAL with GMP certification is opened in Chile.
2011
Business operations are started in Belize through a local distributor.
2012
SAVAL’s plant in Chile is certified by INVIMA, Colombia.
2015
Laboratorios SAVAL’s administrative building is opened in Chile.
2016
Business operations are started in Guatemala through a local distributor.
2016
SAVAL’s plant in Chile is certified by DIGEMID, Peru.
2018
Launch of Biosimilars in Chile based on authorizations in high-surveillance countries.
2021
The women’s health product line is launched.
2021
The Covid-19 vaccine (CanSinoBio) is launched.
2022
SAVAL Investments S.L. is created.
2022
A subsidiary in Costa Rica, Laboratorios SAVAL Costa Rica S.A., is created to drive growth in the region.
2022
A susbidiary in Costa Rica, Laboratorios SAVAL Panamá Inc., is created to drive growth in the region.